Synthesis of 2‐Aryl(alkyl)benzimidazole Hydroxamic Acids as HDAC Inhibitors with Anti‐Angiogenesis Properties

Documenti analoghi

• Heterocycles–Containing HDAC Inhibitors Active in Cancer: An Overview of the Last Fifteen Years
  di: Alessia Raucci, et al.
  Pubblicazione: (2024)
• Modulation of Tau Protein Neurotoxic Hallmarks by Novel σ 1 R Agonists/HDAC Inhibitor Dual‐Acting Compounds
  di: Antonino N. Fallica, et al.
  Pubblicazione: (2026)
• Novel Folate–Phenylfuran P‐gp Inhibitor Conjugates for Overcoming Multidrug Resistance in MCF‐7/ADR Cell
  di: Qin Wang, et al.
  Pubblicazione: (2025)
• Glyoxalase‐1 Inhibition Leads to Ferroptosis Induction in Lung Cancer Cells: A Dual Mechanism of Action of Hydroxamic Acids Derived from Cysteine
  di: Josué Martínez‐Miranda, et al.
  Pubblicazione: (2025)
• PROTAC‐Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies
  di: Ambati Himaja, et al.
  Pubblicazione: (2025)